C4 Therapeutics, Inc. Annual Nonoperating Income (Expense) in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
C4 Therapeutics, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2019 to 2023.
  • C4 Therapeutics, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2024 was $3.58M, a 102% increase year-over-year.
  • C4 Therapeutics, Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was $14.1M, a 136% increase year-over-year.
  • C4 Therapeutics, Inc. annual Nonoperating Income (Expense) for 2023 was $7.82M, a 475% increase from 2022.
  • C4 Therapeutics, Inc. annual Nonoperating Income (Expense) for 2022 was $1.36M.
  • C4 Therapeutics, Inc. annual Nonoperating Income (Expense) for 2021 was -$1.76M, a 73% increase from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $7.82M +$6.46M +475% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-22
2022 $1.36M +$3.12M Jan 1, 2022 Dec 31, 2022 10-K 2024-02-22
2021 -$1.76M +$4.75M +73% Jan 1, 2021 Dec 31, 2021 10-K 2023-02-23
2020 -$6.51M -$8.67M -402% Jan 1, 2020 Dec 31, 2020 10-K 2022-02-24
2019 $2.16M Jan 1, 2019 Dec 31, 2019 10-K 2022-02-24
* An asterisk sign (*) next to the value indicates that the value is likely invalid.